Van ECK Associates Corp decreased its holdings in Quintiles Transitional Holdings Inc. (NYSE:Q) by 8.0% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 518,395 shares of the medical research company’s stock after selling 45,303 shares during the period. Van ECK Associates Corp owned about 0.24% of Quintiles Transitional Holdings worth $46,396,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the business. Fiduciary Trust Co. bought a new position in shares of Quintiles Transitional Holdings during the second quarter worth approximately $105,000. Global X Management Co. LLC increased its stake in shares of Quintiles Transitional Holdings by 30.8% during the first quarter. Global X Management Co. LLC now owns 1,469 shares of the medical research company’s stock worth $118,000 after purchasing an additional 346 shares during the period. Korea Investment CORP increased its stake in shares of Quintiles Transitional Holdings by 142.5% during the second quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock worth $123,000 after purchasing an additional 805 shares during the period. Archford Capital Strategies LLC bought a new position in shares of Quintiles Transitional Holdings during the first quarter worth approximately $160,000. Finally, Bbva Compass Bancshares Inc. increased its stake in shares of Quintiles Transitional Holdings by 4.2% during the second quarter. Bbva Compass Bancshares Inc. now owns 2,204 shares of the medical research company’s stock worth $197,000 after purchasing an additional 88 shares during the period. Hedge funds and other institutional investors own 91.34% of the company’s stock.

A number of equities analysts have commented on the company. Credit Suisse Group restated an “outperform” rating and set a $96.00 price objective (up previously from $94.00) on shares of Quintiles Transitional Holdings in a research note on Tuesday, June 6th. Citigroup Inc. restated a “neutral” rating and set a $96.00 price objective (up previously from $87.00) on shares of Quintiles Transitional Holdings in a research note on Wednesday, June 28th. Robert W. Baird upgraded Quintiles Transitional Holdings from an “underperform” rating to a “neutral” rating and raised their price objective for the stock from $76.00 to $93.00 in a research note on Friday, July 7th. Barclays PLC restated an “overweight” rating and set a $98.00 price objective (up previously from $90.00) on shares of Quintiles Transitional Holdings in a research note on Monday, July 17th. Finally, Zacks Investment Research upgraded Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 price objective on the stock in a research note on Thursday, July 27th. Eleven investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Quintiles Transitional Holdings has a consensus rating of “Buy” and a consensus target price of $92.44.

TRADEMARK VIOLATION WARNING: “Quintiles Transitional Holdings Inc. (Q) Shares Sold by Van ECK Associates Corp” was first published by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.dailypolitical.com/2017/09/20/quintiles-transitional-holdings-inc-q-shares-sold-by-van-eck-associates-corp.html.

Quintiles Transitional Holdings Inc. (Q) traded down 0.19% during midday trading on Wednesday, hitting $94.82. The company had a trading volume of 166,531 shares. Quintiles Transitional Holdings Inc. has a 52 week low of $70.10 and a 52 week high of $99.95. The firm’s 50 day moving average is $93.80 and its 200-day moving average is $86.86. The firm has a market capitalization of $20.53 billion, a P/E ratio of 274.84 and a beta of 0.63.

Quintiles Transitional Holdings (NYSE:Q) last released its earnings results on Thursday, August 3rd. The medical research company reported $1.09 EPS for the quarter, beating the Zacks’ consensus estimate of $1.05 by $0.04. Quintiles Transitional Holdings had a return on equity of 14.23% and a net margin of 0.82%. The business had revenue of $1.97 billion for the quarter, compared to analysts’ expectations of $1.96 billion. During the same quarter in the prior year, the firm earned $0.93 earnings per share. The firm’s revenue was up 68.7% on a year-over-year basis. On average, equities research analysts expect that Quintiles Transitional Holdings Inc. will post $4.58 EPS for the current fiscal year.

Quintiles Transitional Holdings declared that its board has initiated a share buyback program on Wednesday, May 24th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the medical research company to repurchase up to 5.4% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board of directors believes its shares are undervalued.

In other news, insider Kevin C. Knightly sold 20,000 shares of the stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $90.28, for a total transaction of $1,805,600.00. Following the completion of the sale, the insider now directly owns 46,826 shares in the company, valued at $4,227,451.28. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Ari Bousbib sold 92,160 shares of the stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $90.35, for a total transaction of $8,326,656.00. Following the sale, the insider now owns 1,082,919 shares of the company’s stock, valued at $97,841,731.65. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,363,847 shares of company stock valued at $618,573,696. Company insiders own 6.40% of the company’s stock.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Want to see what other hedge funds are holding Q? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quintiles Transitional Holdings Inc. (NYSE:Q).

Institutional Ownership by Quarter for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.